Holocene Advisors LP Purchases Shares of 212,096 Bath & Body Works, Inc. (NYSE:BBWI)

Holocene Advisors LP acquired a new position in Bath & Body Works, Inc. (NYSE:BBWI) in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 212,096 shares of the company’s stock, valued at approximately $6,770,000.

Several other institutional investors have also recently made changes to their positions in BBWI. CWM LLC grew its holdings in Bath & Body Works by 6.6% during the 2nd quarter. CWM LLC now owns 5,072 shares of the company’s stock valued at $198,000 after buying an additional 314 shares in the last quarter. DekaBank Deutsche Girozentrale increased its holdings in Bath & Body Works by 1.0% in the 1st quarter. DekaBank Deutsche Girozentrale now owns 31,797 shares of the company’s stock valued at $1,560,000 after acquiring an additional 322 shares during the last quarter. Citizens & Northern Corp lifted its stake in Bath & Body Works by 1.7% in the 2nd quarter. Citizens & Northern Corp now owns 29,465 shares of the company’s stock worth $1,151,000 after purchasing an additional 487 shares in the last quarter. Blue Trust Inc. boosted its holdings in shares of Bath & Body Works by 23.4% during the 2nd quarter. Blue Trust Inc. now owns 2,767 shares of the company’s stock valued at $108,000 after purchasing an additional 524 shares during the last quarter. Finally, GAMMA Investing LLC increased its holdings in shares of Bath & Body Works by 34.4% in the third quarter. GAMMA Investing LLC now owns 2,481 shares of the company’s stock worth $79,000 after purchasing an additional 635 shares during the last quarter. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Insider Transactions at Bath & Body Works

In other Bath & Body Works news, CEO Gina Boswell acquired 6,000 shares of the stock in a transaction that occurred on Wednesday, October 9th. The stock was bought at an average cost of $29.64 per share, with a total value of $177,840.00. Following the completion of the purchase, the chief executive officer now directly owns 242,987 shares in the company, valued at $7,202,134.68. The trade was a 2.53 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.27% of the company’s stock.

Bath & Body Works Trading Down 1.6 %

Shares of BBWI opened at $36.90 on Wednesday. The firm has a fifty day moving average price of $31.33 and a 200-day moving average price of $35.30. The firm has a market capitalization of $7.99 billion, a P/E ratio of 9.00, a P/E/G ratio of 1.40 and a beta of 1.83. Bath & Body Works, Inc. has a 12-month low of $26.20 and a 12-month high of $52.99.

Bath & Body Works (NYSE:BBWI) last issued its earnings results on Monday, November 25th. The company reported $0.49 EPS for the quarter, topping analysts’ consensus estimates of $0.46 by $0.03. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The business had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.58 billion. During the same period in the prior year, the firm earned $0.48 EPS. The company’s revenue for the quarter was up 3.1% compared to the same quarter last year. Analysts predict that Bath & Body Works, Inc. will post 3.26 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Friday, November 22nd will be given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 2.17%. The ex-dividend date is Friday, November 22nd. Bath & Body Works’s dividend payout ratio (DPR) is presently 19.51%.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the company. Wells Fargo & Company increased their price target on Bath & Body Works from $32.00 to $38.00 and gave the company an “equal weight” rating in a research note on Tuesday, November 26th. Piper Sandler boosted their price target on shares of Bath & Body Works from $35.00 to $36.00 and gave the stock a “neutral” rating in a research report on Tuesday, November 26th. Telsey Advisory Group reaffirmed an “outperform” rating and set a $42.00 price target on shares of Bath & Body Works in a research note on Monday, November 25th. Robert W. Baird dropped their price objective on shares of Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating for the company in a research note on Thursday, August 29th. Finally, UBS Group decreased their target price on shares of Bath & Body Works from $52.00 to $38.00 and set a “neutral” rating on the stock in a research report on Thursday, August 29th. One research analyst has rated the stock with a sell rating, six have given a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat, Bath & Body Works presently has a consensus rating of “Moderate Buy” and a consensus price target of $41.88.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.